Breaking News

PharmEng Restructures

PharmEng International Inc. has decided to reduce corporate costs as part of its ongoing restructuring efforts.

PharmEng International Inc. has decided to reduce corporate costs as part of its ongoing restructuring efforts. Chief financial officer Brian Fielding, vice president of marketing John Durham and vice president Charles Ivey have left the company, while chief executive officer Alan Kwong has taken a 50% salary reduction.

In addition, several members of the company’s board have resigned: Bernard Boudreau, Edgar Parker, Aditya Jah, Vasu Chanchlani and Michael Sefton.



Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters